Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × lenvatinib × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 34 INDUSTRY 25 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Adrenocortical Carcinoma 1

Interventions

pembrolizumab 4 Capecitabine 4 tislelizumab 3 Radiosurgery 2 Oxaliplatin 2 Observation 2 Metformin 2 Drug Therapy 2 Bevacizumab 2 trilaciclib 1 trastuzumab deruxtecan 1 spartalizumab 1 lenvatinib 1 ivarmacitinib 1 ferric maltol 1 durvalumab 1 defactinib 1 decitabine and cedazuridine drug combination 1 dalpiciclib 1 cedazuridine 1 bemarituzumab 1 atezolizumab 1 anlotinib 1 XELOX 1 Vitamin D 1 Videotape Recording 1 Tranexamic Acid 1 Synbiotics 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05036434 2026-01-23

ACCOMPLISH

National Cancer Center, Korea

Phase 2 Active not recruiting

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡